Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$59.00T
24h Vol:
$10.08B
Dominance:
MSFT:5.13%
Stocklytics Platform
BETA
Instrument logo  ZTS

Zoetis Inc

ZTS
68 / 100
S&P500
$199.00arrow_drop_up0.99%$1.96

Performance History

Stocklytics logo
Key Stats
Open$197.35
Prev. Close$196.66
EPS5.07
Dividend$1.50
Next Earnings DateSep 9, 2024
Dividend Yield %0.88%
Market Cap$90.29B
PE Ratio38.90
LOWHIGH
Day Range194.82
198.21
52 Week Range151.03
201.92
Ratios
P/B Ratio18.07
Revenue$8.54B
Operating M. %32.17%
Earnings$2.34B
Earnings Growth %10.85%
EBITDA Margin %40.82%
ROE %49.82%
EPS5.07

Score Breakdown

68vs 53. Market Avg.

All Score 68 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

ZTSMARKET
Value2439
Quality7040
Ownership4119
Growth6646
Dividends3537
check_circle

Zoetis Inc's Price growth average in the last 3 years of 9.41% is great compared to market average of 6.47%. This indicates ZTS could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$765.00
24H (%)arrow_drop_down-0.89%
24H ($)-$6.91
MARKET CAP$726.87B
PRICE$513.41
24H (%)arrow_drop_down-2.26%
24H ($)-$11.90
MARKET CAP$474.87B
PRICE$160.98
24H (%)arrow_drop_up0.11%
24H ($)$0.19
MARKET CAP$387.76B
PRICE$129.03
24H (%)arrow_drop_up0.14%
24H ($)$0.19
MARKET CAP$326.96B

About Zoetis Inc (ZTS)

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Ms. Kristin C. Peck
Headquarters
Parsippany
Employees
13800
Exchange
NYSE
add Zoetis Inc to watchlist

Keep an eye on Zoetis Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is Zoetis Inc's (ZTS) price per share?

The current price per share for Zoetis Inc (ZTS) is $199. The stock has seen a price change of $1.96 recently, indicating a 0.99% change. This reflects the stock's recent market performance and investor sentiment.

question_mark
What is the 52-week high and low for Zoetis Inc (ZTS)?

For Zoetis Inc (ZTS), the 52-week high is $201.92, which is 1.47% from the current price. The 52-week low is $151.03, the current price is 31.76% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

question_mark
Is Zoetis Inc (ZTS) a growth stock?

Zoetis Inc (ZTS) has shown an average price growth of 9.11% over the past three years. It has received a score of 73 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Zoetis Inc as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

question_mark
What is Zoetis Inc (ZTS) stock price performance year to date (YTD)?

As of the latest data, Zoetis Inc (ZTS) has a year-to-date price change of 1.22%. Over the past month, the stock has experienced a price change of 3.21%. Over the last three months, the change has been 12.49%. Looking at a longer horizon, the five-year price change stands at 111.19%.

question_mark
Is Zoetis Inc (ZTS) a profitable company?

Zoetis Inc (ZTS) has a net income of $2.34B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 70.03% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 32.17% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.54B, with a revenue growth rate of 5.74%, providing insight into the company's sales performance and growth. The gross profit is $5.98B. Operating income is noted at $3.22B. Furthermore, the EBITDA is $3.7B.

question_mark
What is the market capitalization of Zoetis Inc (ZTS)?

Zoetis Inc (ZTS) has a market capitalization of $91.12B. The average daily trading volume is 2.7M, indicating the stock's liquidity and investor engagement.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.